International Patent: USE OF MEMBRANE ANCHORING PROTEIN MOTIF AS A MEANS OF LYTIC GRANULE REPOSITIONING TO THE CELLULAR CORTEX TO INCREASE BYSTANDER KILLING AS AN ADJUVANT FOR SOLID TUMOR CELL THERAPY

GENEVA, July 9 -- THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK filed a patent application (US2026/010305) for “USE OF MEMBRANE ANCHORING PROTEIN MOTIF AS A MEANS OF LYTIC GRANULE REPOSITIONING TO THE CELLULAR CORTEX TO INCREASE BYSTANDER KILLING AS AN ADJUVANT FOR SOLID TUMOR CELL THERAPY”. With publication no. WO/2026/148332, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: G01N 33/50

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....